Dallah Healthcare Company

Informe acción SASE:4004

Capitalización de mercado: ر.س16.1b

Dallah Healthcare Resultados de beneficios anteriores

Pasado controles de criterios 5/6

Dallah Healthcare ha aumentado sus beneficios a una tasa media anual de 23.7%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento de 11.9% anual. Los ingresos han ido creciendo a una tasa media de 21.4% al año. La rentabilidad financiera de Dallah Healthcare es de 11.1%, y sus márgenes netos son de 12.2%.

Información clave

24.8%

Tasa de crecimiento de los beneficios

22.7%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare 12.3%
Tasa de crecimiento de los ingresos21.6%
Rentabilidad financiera11.4%
Margen neto12.8%
Última actualización de beneficios31 Mar 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist

May 30
Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist

We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

Apr 16
We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E

Mar 18
What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E

Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes

Feb 25
Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes

Dallah Healthcare (TADAWUL:4004) Has More To Do To Multiply In Value Going Forward

Oct 30
Dallah Healthcare (TADAWUL:4004) Has More To Do To Multiply In Value Going Forward

Dallah Healthcare (TADAWUL:4004) Is Reinvesting At Lower Rates Of Return

Jul 26
Dallah Healthcare (TADAWUL:4004) Is Reinvesting At Lower Rates Of Return

Returns On Capital Signal Tricky Times Ahead For Dallah Healthcare (TADAWUL:4004)

Apr 17
Returns On Capital Signal Tricky Times Ahead For Dallah Healthcare (TADAWUL:4004)

Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Feb 06
Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Dallah Healthcare (TADAWUL:4004) Will Want To Turn Around Its Return Trends

Dec 05
Dallah Healthcare (TADAWUL:4004) Will Want To Turn Around Its Return Trends

We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

Nov 01
We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

Calculating The Intrinsic Value Of Dallah Healthcare Company (TADAWUL:4004)

Aug 28
Calculating The Intrinsic Value Of Dallah Healthcare Company (TADAWUL:4004)

Dallah Healthcare (TADAWUL:4004) Has Some Way To Go To Become A Multi-Bagger

Aug 12
Dallah Healthcare (TADAWUL:4004) Has Some Way To Go To Become A Multi-Bagger

Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Jul 28
Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Industry Analysts Just Upgraded Their Dallah Healthcare Company (TADAWUL:4004) Revenue Forecasts By 10%

May 26
Industry Analysts Just Upgraded Their Dallah Healthcare Company (TADAWUL:4004) Revenue Forecasts By 10%

Calculating The Fair Value Of Dallah Healthcare Company (TADAWUL:4004)

May 20
Calculating The Fair Value Of Dallah Healthcare Company (TADAWUL:4004)

Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Apr 16
Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Feb 03
Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Jan 10
Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Oct 19
Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Jul 09
Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Forecast: Analysts Think Dallah Healthcare Company's (TADAWUL:4004) Business Prospects Have Improved Drastically

Jun 16
Forecast: Analysts Think Dallah Healthcare Company's (TADAWUL:4004) Business Prospects Have Improved Drastically

Broker Revenue Forecasts For Dallah Healthcare Company (TADAWUL:4004) Are Surging Higher

May 02
Broker Revenue Forecasts For Dallah Healthcare Company (TADAWUL:4004) Are Surging Higher

What Kind Of Shareholders Hold The Majority In Dallah Healthcare Company's (TADAWUL:4004) Shares?

Mar 17
What Kind Of Shareholders Hold The Majority In Dallah Healthcare Company's (TADAWUL:4004) Shares?

Has Dallah Healthcare (TADAWUL:4004) Got What It Takes To Become A Multi-Bagger?

Mar 02
Has Dallah Healthcare (TADAWUL:4004) Got What It Takes To Become A Multi-Bagger?

Dallah Healthcare (TADAWUL:4004) Shareholders Booked A 45% Gain In The Last Year

Feb 15
Dallah Healthcare (TADAWUL:4004) Shareholders Booked A 45% Gain In The Last Year

Should You Buy Dallah Healthcare Company (TADAWUL:4004) For Its Dividend?

Feb 01
Should You Buy Dallah Healthcare Company (TADAWUL:4004) For Its Dividend?

Are Dallah Healthcare's (TADAWUL:4004) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Jan 05
Are Dallah Healthcare's (TADAWUL:4004) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Dallah Healthcare Company's (TADAWUL:4004) Intrinsic Value Is Potentially 26% Below Its Share Price

Dec 22
Dallah Healthcare Company's (TADAWUL:4004) Intrinsic Value Is Potentially 26% Below Its Share Price

Will Dallah Healthcare (TADAWUL:4004) Multiply In Value Going Forward?

Nov 20
Will Dallah Healthcare (TADAWUL:4004) Multiply In Value Going Forward?

Desglose de ingresos y gastos

Cómo gana y gasta dinero Dallah Healthcare. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

SASE:4004 Ingresos, gastos y beneficios (SAR Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
31 Mar 243,0103855650
31 Dec 232,9433605490
30 Sep 232,8313255370
30 Jun 232,6822705090
31 Mar 232,5952864560
31 Dec 222,4882744430
30 Sep 222,3703054640
30 Jun 222,3133114500
31 Mar 222,2202894340
31 Dec 212,1052594160
30 Sep 211,9352024020
30 Jun 211,7422063710
31 Mar 211,4981653310
31 Dec 201,3181323070
30 Sep 201,2571502770
30 Jun 201,2071232720
31 Mar 201,2461312870
31 Dec 191,2521472860
30 Sep 191,2271103040
30 Jun 191,2061152950
31 Mar 191,1931192930
31 Dec 181,1811422860
30 Sep 181,1891722810
30 Jun 181,2032172740
31 Mar 181,2182682600
31 Dec 171,2122952460
30 Sep 171,2022842540
30 Jun 171,1802682650
31 Mar 171,1812522750
31 Dec 161,1632252880
30 Sep 161,1222282640
30 Jun 161,0731942550
31 Mar 161,0301752490
31 Dec 159851652310
30 Sep 159481612190
30 Jun 159171562110
31 Mar 158921542060
31 Dec 148591472010
30 Sep 148311492030
30 Jun 148051491940
31 Mar 147731381840
31 Dec 137501371820
30 Sep 137181191720
30 Jun 136931211630

Ingresos de calidad: 4004 tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio (12.2%) de 4004 son superiores a los del año pasado (11%).


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: En los últimos 5 años, los beneficios de l4004 han crecido significativamente en un 23.7% al año.

Acelerando crecimiento: El crecimiento de los beneficios de 4004 en el último año (31.2%) supera su media de 5 años (23.7% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de 4004 en el último año (31.2%) superó al de la industria Healthcare 23.9%.


Rentabilidad financiera

Alta ROE: La rentabilidad financiera de 4004 (11.1%) se considera baja.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado